Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8815906 Tyrosine kinase inhibitors

Patent 8815906 was granted and assigned to Chembridge Corporation on August, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Chembridge Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8815906

Patent Inventor Names

Aleksander Kadushkin0

Alexander Chucholowski0

Alexey Vyacheslavovich Anikin0

Alisher Khasanov0

Charles Chamchoumis Mikel0

Douglas Eric McGrath0

Goverdhan Reddy Vavilala0

Jason Conrad Pickens0

...

Date of Patent

August 26, 2014

Patent Application Number

12922891

Date Filed

March 18, 2009

Patent Citations Received

‌

US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

‌

US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors

‌

US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors

Patent Primary Examiner

‌

Zinna Northington Davis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8815906 Tyrosine kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API